With the failure of AbbVie’s emraclidine in two mid-stage trials, Bristol Myers Squibb’s Cobenfy is 'sole muscarinic winner.' ...
Cobenfy is a combination of a muscarinic M1 ... selective muscarinic M4 agonist NBI-1117568 hit the mark in a phase 2 schizophrenia study in August, leaving emraclidine looking like an outlier ...
All patients met International Classification of Diseases (ICD)-10 and Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria for schizophrenia. Patients had to have ...
Min-Wei Huang; Tsung-Tsair Yang; Po-Ren Ten; Po-Wen Su; Bo-Jian Wu; Chin-Hong Chan; Tsuo-Hung Lan; I-Chao Liu; Wei-Cheh Chiu; Chun-Ying Li; Kuo-Sheng Cheng; Yu-Chi Yeh ...
Why the iPhone SE 4 Could Be One of Apple's Most Important Products of 2025 ...
All our text and photo updates as Australia claim the series following a close finish after Pakistan’s late fightback. All our updates as world champions India beat hosts South Africa at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback